Related Experiment Video
Updated: Jul 8, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability
Gaël G McGill1, Martin Horstmann, Hans R Widlund
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
Kit/SCF signaling and Mitf-dependent transcription are both essential for melanocyte development and pigmentation. To identify Mitf-dependent Kit transcriptional targets in primary melanocytes, microarray studies were undertaken. Among identified targets was BCL2, whose germline deletion produces melanocyte loss and which exhibited phenotypic synergy with Mitf in mice. BCL2's regulation by Mitf was verified in melanocytes and melanoma cells and by chromatin immunoprecipitation of the BCL2 promoter. Mitf also regulates BCL2 in osteoclasts, and both Mitf(mi/mi) and Bcl2(-/-) mice exhibit severe osteopetrosis. Disruption of Mitf in melanocytes or melanoma triggered profound apoptosis susceptible to rescue by BCL2 overexpression. Clinically, primary human melanoma expression microarrays revealed tight nearest neighbor linkage for MITF and BCL2. This linkage helps explain the vital roles of both Mitf and Bcl2 in the melanocyte lineage and the well-known treatment resistance of melanoma.
Insights
Microphthalmia-associated transcription factor (Mitf) regulates BCL2, a gene crucial for melanocyte survival. This Mitf-BCL2 connection is vital for melanocyte development and melanoma treatment resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Kit/SCF signaling and Mitf-dependent transcription are critical for melanocyte development and pigmentation.
- Mitf is a key transcription factor regulating melanocyte-specific genes.
Purpose of the Study:
- To identify Mitf-dependent transcriptional targets in primary melanocytes.
- To investigate the functional relationship between Mitf and BCL2 in melanocytes and melanoma.
Main Methods:
- Microarray analysis to identify Mitf targets.
- Chromatin immunoprecipitation to verify promoter binding.
- Analysis of mouse models with genetic disruptions (Mitf and Bcl2).
- Examination of human melanoma expression data.
Main Results:
- BCL2 was identified as a Mitf-dependent transcriptional target.
- Mitf directly regulates BCL2 expression in melanocytes, melanoma cells, and osteoclasts.
- Mice lacking Mitf or BCL2 exhibit osteopetrosis.
- Mitf disruption induces apoptosis in melanocytes and melanoma, which can be rescued by BCL2.
- MITF and BCL2 show correlated expression in human melanoma.
Conclusions:
- Mitf and BCL2 play synergistic roles in melanocyte lineage survival.
- The Mitf-BCL2 regulatory axis is essential for melanocyte development and pigmentation.
- This linkage provides insight into melanoma treatment resistance.
Related Concept Videos
Negative Regulator Molecules
Master Transcription Regulators
Mitogens and the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle

